Exome Sequencing and Systems Biology Converge to Identify Novel Mutations in the L-Type Calcium Channel, CACNA1C, Linked to Autosomal Dominant Long QT Syndrome

Background—Long QT syndrome (LQTS) is the most common cardiac channelopathy with 15 elucidated LQTS-susceptibility genes. Approximately 20% of LQTS cases remain genetically elusive. Methods and Results—We combined whole-exome sequencing and bioinformatic/systems biology to identify the pathogenic substrate responsible for nonsyndromic, genotype-negative, autosomal dominant LQTS in a multigenerational pedigree, and we established the spectrum and prevalence of variants in the elucidated gene among a cohort of 102 unrelated patients with “genotype-negative/phenotype-positive” LQTS. Whole-exome sequencing was used on 3 members within a genotype-negative/phenotype-positive family. Genomic triangulation combined with bioinformatic tools and ranking algorithms led to the identification of a CACNA1C mutation. This mutation, Pro857Arg-CACNA1C, cosegregated with the disease within the pedigree, was ranked by 3 disease-network algorithms as the most probable LQTS-susceptibility gene and involves a conserved residue localizing to the proline, gltamic acid, serine, and threonine (PEST) domain in the II-III linker. Functional studies reveal that Pro857Arg-CACNA1C leads to a gain of function with increased ICa,L and increased surface membrane expression of the channel compared to wild type. Subsequent mutational analysis identified 3 additional variants within CACNA1C in our cohort of 102 unrelated cases of genotype-negative/phenotype-positive LQTS. Two of these variants also involve conserved residues within Cav1.2’s PEST domain. Conclusions—This study provides evidence that coupling whole-exome sequencing and bioinformatic/systems biology is an effective strategy for the identification of potential disease-causing genes/mutations. The identification of a functional CACNA1C mutation cosegregating with disease in a single pedigree suggests that CACNA1C perturbations may underlie autosomal dominant LQTS in the absence of Timothy syndrome.

[1]  Arthur J Moss,et al.  Long QT syndrome: from channels to cardiac arrhythmias. , 2005, The Journal of clinical investigation.

[2]  J. Benitah,et al.  L-type Ca(2+) current in ventricular cardiomyocytes. , 2010, Journal of molecular and cellular cardiology.

[3]  D. Friedlander,et al.  The congenital long QT syndrome. , 1989, The New Zealand medical journal.

[4]  David J. Porteous,et al.  Speeding disease gene discovery by sequence based candidate prioritization , 2005, BMC Bioinformatics.

[5]  M. DePristo,et al.  The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data. , 2010, Genome research.

[6]  S. Shaughnessy,et al.  Do No Harm: Health Systems’ Duty to Promote Clinician Well-Being , 2022, American Journal of Hospital Medicine.

[7]  J. Shendure,et al.  Exome sequencing as a tool for Mendelian disease gene discovery , 2011, Nature Reviews Genetics.

[8]  K. Reinier,et al.  Epidemiology of sudden cardiac death: clinical and research implications. , 2008, Progress in cardiovascular diseases.

[9]  R. Liberthson,et al.  Sudden death from cardiac causes in children and young adults. , 1996, The New England journal of medicine.

[10]  S. Rogers,et al.  PEST sequences and regulation by proteolysis. , 1996, Trends in biochemical sciences.

[11]  Yaniv Erlich,et al.  Exome sequencing and disease-network analysis of a single family implicate a mutation in KIF1A in hereditary spastic paraparesis. , 2011, Genome research.

[12]  Christopher Gignoux,et al.  The 1000 Genomes Project: new opportunities for research and social challenges , 2010, Genome Medicine.

[13]  Ying Li,et al.  TREAT: a bioinformatics tool for variant annotations and visualizations in targeted and exome sequencing data , 2011, Bioinform..

[14]  Elizabeth M. Smigielski,et al.  dbSNP: a database of single nucleotide polymorphisms , 2000, Nucleic Acids Res..

[15]  S. Priori,et al.  Genetic testing in the long QT syndrome: development and validation of an efficient approach to genotyping in clinical practice. , 2005, JAMA.

[16]  Michael J Ackerman,et al.  Postmortem long QT syndrome genetic testing for sudden unexplained death in the young. , 2007, Journal of the American College of Cardiology.

[17]  D. Tester,et al.  Compendium of cardiac channel mutations in 541 consecutive unrelated patients referred for long QT syndrome genetic testing. , 2005, Heart rhythm.

[18]  J. Hell,et al.  Supramolecular assemblies and localized regulation of voltage-gated ion channels. , 2009, Physiological reviews.

[19]  P. Schwartz,et al.  Electrocardiographic Features in Andersen-Tawil Syndrome Patients With KCNJ2 Mutations: Characteristic T-U–Wave Patterns Predict the KCNJ2 Genotype , 2005, Circulation.

[20]  S. Priori,et al.  CaV1.2 Calcium Channel Dysfunction Causes a Multisystem Disorder Including Arrhythmia and Autism , 2004, Cell.

[21]  Seth I. Berger,et al.  Systems Pharmacology of Arrhythmias , 2010, Science Signaling.

[22]  Eleazar Eskin,et al.  An Optimal Weighted Aggregated Association Test for Identification of Rare Variants Involved in Common Diseases , 2011, Genetics.

[23]  A. Zuccotti,et al.  Structural and functional differences between L-type calcium channels: crucial issues for future selective targeting. , 2011, Trends in pharmacological sciences.

[24]  C. January,et al.  Small GTPase Rab11b regulates degradation of surface membrane L-type Cav1.2 channels. , 2011, American journal of physiology. Cell physiology.

[25]  Michael J Ackerman,et al.  HRS/EHRA expert consensus statement on the state of genetic testing for the channelopathies and cardiomyopathies: this document was developed as a partnership between the Heart Rhythm Society (HRS) and the European Heart Rhythm Association (EHRA). , 2011, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[26]  Martin Tristani-Firouzi,et al.  Kir 2.1 channelopathies: the Andersen–Tawil syndrome , 2010, Pflügers Archiv - European Journal of Physiology.

[27]  K. Elmslie,et al.  The Timothy syndrome mutation of cardiac CaV1.2 (L‐type) channels: multiple altered gating mechanisms and pharmacological restoration of inactivation , 2009, The Journal of physiology.

[28]  Jing Chen,et al.  Improved human disease candidate gene prioritization using mouse phenotype , 2007, BMC Bioinformatics.

[29]  Frank B Sachse,et al.  Severe arrhythmia disorder caused by cardiac L-type calcium channel mutations. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[30]  A. Wilde,et al.  Spectrum and prevalence of mutations from the first 2,500 consecutive unrelated patients referred for the FAMILION long QT syndrome genetic test. , 2009, Heart rhythm.

[31]  Huanming Yang,et al.  Resequencing of 200 human exomes identifies an excess of low-frequency non-synonymous coding variants , 2010, Nature Genetics.

[32]  C. Wijmenga,et al.  Exome sequencing in a family segregating for celiac disease , 2011, Clinical genetics.

[33]  S. Rogers,et al.  Amino acid sequences common to rapidly degraded proteins: the PEST hypothesis. , 1986, Science.

[34]  D. Catalucci,et al.  Akt regulates L-type Ca2+ channel activity by modulating Cavα1 protein stability , 2009, The Journal of cell biology.

[35]  Richard Durbin,et al.  Sequence analysis Fast and accurate short read alignment with Burrows – Wheeler transform , 2009 .

[36]  Kevin P. Murphy,et al.  SNVMix: predicting single nucleotide variants from next-generation sequencing of tumors , 2010, Bioinform..

[37]  R. Dolmetsch,et al.  The CRAC Channel Activator STIM1 Binds and Inhibits L-Type Voltage-Gated Calcium Channels , 2010, Science.

[38]  Michel Haïssaguerre,et al.  Loss-of-Function Mutations in the Cardiac Calcium Channel Underlie a New Clinical Entity Characterized by ST-Segment Elevation, Short QT Intervals, and Sudden Cardiac Death , 2007, Circulation.

[39]  Fabio Mosca,et al.  Prevalence of the Congenital Long-QT Syndrome , 2009, Circulation.

[40]  C. Antzelevitch,et al.  Long QT, syndactyly, joint contractures, stroke and novel CACNA1C mutation: Expanding the spectrum of Timothy syndrome , 2012, American journal of medical genetics. Part A.

[41]  J. Healey,et al.  Recommendations for the use of genetic testing in the clinical evaluation of inherited cardiac arrhythmias associated with sudden cardiac death: Canadian Cardiovascular Society/Canadian Heart Rhythm Society joint position paper. , 2011, The Canadian journal of cardiology.

[42]  Deborah A Nickerson,et al.  Genome-wide studies of copy number variation and exome sequencing identify rare variants in BAG3 as a cause of dilated cardiomyopathy. , 2011, American journal of human genetics.

[43]  D. Catalucci,et al.  Akt regulates L-type Ca2+ channel activity by modulating Cavα1 protein stability , 2009, The Journal of Cell Biology.

[44]  S. Eguchi,et al.  The Calcium Store Sensor, STIM1, Reciprocally Controls Orai and CaV1.2 Channels , 2010, Science.

[45]  Bassem A. Hassan,et al.  Gene prioritization through genomic data fusion , 2006, Nature Biotechnology.

[46]  Electrical remodeling in hearts from a calcium-dependent mouse model of hypertrophy and failure: complex nature of K+ current changes and action potential duration. , 2003, Journal of the American College of Cardiology.